Khiron Life Sciences Corp
Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis. It also operates a network of health centers and s… Read more
Market Cap & Net Worth: Khiron Life Sciences Corp (KHRNF)
Khiron Life Sciences Corp (PINK:KHRNF) has a market capitalization of $23.24K ($23.24K) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #43799 globally and #13966 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Khiron Life Sciences Corp's stock price $0.00 by its total outstanding shares 232408992 (232.41 Million).
Khiron Life Sciences Corp Market Cap History: 2018 to 2024
Khiron Life Sciences Corp's market capitalization history from 2018 to 2024. Data shows change from $260.30 Million to $23.24K (-75.06% CAGR).
Khiron Life Sciences Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Khiron Life Sciences Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
3.00x
Khiron Life Sciences Corp's market cap is 3.00 times its annual revenue
1.02x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $260.30 Million | $891.68K | -$19.81 Million | 291.92x | N/A |
| 2019 | $187.46 Million | $9.58 Million | -$36.38 Million | 19.56x | N/A |
| 2020 | $68.84 Million | $8.02 Million | -$24.04 Million | 8.59x | N/A |
| 2021 | $38.35 Million | $12.79 Million | -$33.13 Million | 3.00x | N/A |
Competitor Companies of KHRNF by Market Capitalization
Companies near Khiron Life Sciences Corp in the global market cap rankings as of March 18, 2026.
Key companies related to Khiron Life Sciences Corp by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Khiron Life Sciences Corp Historical Marketcap From 2018 to 2024
Between 2018 and today, Khiron Life Sciences Corp's market cap moved from $260.30 Million to $ 23.24K, with a yearly change of -75.06%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2024 | $23.24K | -96.67% |
| 2023 | $697.23K | -92.86% |
| 2022 | $9.76 Million | -74.55% |
| 2021 | $38.35 Million | -44.29% |
| 2020 | $68.84 Million | -63.28% |
| 2019 | $187.46 Million | -27.98% |
| 2018 | $260.30 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 28th, 2025 the market cap of Khiron Life Sciences Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $23.24K USD |
| MoneyControl | $23.24K USD |
| MarketWatch | $23.24K USD |
| marketcap.company | $23.24K USD |
| Reuters | $23.24K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.